Sergey Ivanov: Russia is ready to open new page in relations with U.S. after electionsRussian Politics & Diplomacy October 24, 4:10
Qatari former Emir Sheikh Khalifa bin Hamad Al Thani dies aged 84World October 23, 23:08
Russia’s health ministry plans to build vaccines plant in EcuadorBusiness & Economy October 23, 20:19
Cygnus cargo spacecraft docks to ISSScience & Space October 23, 19:44
Whereabouts of several residents of blast-destroyed house in Ryazan not yet establishedWorld October 23, 18:50
Zakharova: no cyberattack on Russian foreign ministry’s websiteRussian Politics & Diplomacy October 23, 18:29
Russian Minister of Energy: Russia, Saudi Arabia begin new stage of energy cooperationBusiness & Economy October 23, 17:32
Russia not ready to say whether it will cut oil production or freeze itBusiness & Economy October 23, 17:29
Experts probing into situation around cyberattack on Russian foreign ministry’s websiteRussian Politics & Diplomacy October 23, 17:05
BASEL, January 29. /ITAR-TASS/. Russia ranks second by the pharmaceutical market of over-the-counter medications, goes a report of the multinational pharmaceutical corporation Novartis.
According to the statements, the country became the world's second largest market and the strongest driver in this segment with its “double-digit growth” of over-the-counter drug sales.
As for the brands popular in Russia, Novartis cites anti-inflammatory drug Voltaren, nasal spray Otrivin and cold symptom-fighting powder Theraflu. Growth in sales of the two latter drugs increased due to cold winter, Novartis explains.
2013 financial statements came out on Wednesday showing Novartis’ revenue 2.2% up to 57.92 billion. Net profit declined 1% to 9.3 billion.
The company does not disclose over-the-counter sales summing the figure up with revenue from veterinary drugs. Sales in the segment grew 8.8% to 4.06 billion in 2013.
Novartis International AG set up in 1996 is Europe’s second pharmaceutical producer by market share with 120,000 employees operating in 140 countries. In Russia, Novartis has three kinds of businesses: over-the-counter medications, contact lenses and veterinary drugs.